The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

Research Highlights

Breaking the bonds of pain

Slightest touch can evoke pain in patients suffering from nerve injuries. Researchers of the MDC now have suppressed this type of neuropathic pain in mice by applying a chemical substance to the skin. The method could work in humans.


Only apparently healthy: How titin gene mutations affect heart function

The MDC research group led by Norbert Hübner has discovered that mutations in the titin gene have previously unknown effects on the heart function of healthy individuals. These mutations are present in one percent of the general population.


Further research highlights


EU-LIFE’s vision for the next European Programme FP9

The next Horizon – Strategies to promote European competitiveness in innovation


The neurobiology of gazing out the window of a train

In November's edition of the MDC Lectures, Neurobiologist Botond Roska described how neuronal structures form the basis of the brain's ability to "compute" sensory stimuli.


How to make a motor neuron

Scientists have uncovered details of the cellular mechanisms that control the direct programming of stem cells into motor neurons. The scientists analyzed changes that occur in the cells over the course of the reprogramming process.


Further news on MDC Insights